32.29
32.29 (0.89%)
As of Mar 06, 2024
Cymabay Therapeutics, Inc. [CBAY]
Source:
Company Overview
We are a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases with high unmet medical need.
| Country | United States |
| Headquarters | fremont, california |
| Phone Number | (510) 293-8800 |
| Industry | manufacturing |
| CEO | Sujal Shah |
| Website | www.cymabay.com |